Recently Updated Pages
169 - Clinical management of dyslipidaemia
Clinical management of dyslipidaemia 170 The Maudsley® Prescribing Guidelines in Psychiatry CHAPT...
17 - Recommendations
Recommendations
170 - Summary of monitoring
Summary of monitoring
166 - Olanzapine
Olanzapine Schizophrenia and related psychoses CHAPTER 1 Effects of antipsychotic medications on ...
167 - Clozapine
Clozapine
168 - Screening and monitoring
Screening and monitoring
163 - References
References 166 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Other cardiovascular ...
164 - Effects of antipsychotic medications on plasm
Effects of antipsychotic medications on plasma lipids
165 - Effect of antipsychotic medications on lipids
Effect of antipsychotic medications on lipids
160 - Metabolic inhibition
Metabolic inhibition Schizophrenia and related psychoses CHAPTER 1 Table 1.37 Non-psychotropics...
161 - Other cardiovascular risk factors
Other cardiovascular risk factors
162 - Summary
Summary
158 - Other risk factors
Other risk factors 164 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Aripiprazole ...
159 - ECG monitoring
ECG monitoring
16 - Adverse effects
Adverse effects 18 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 A small number of...
154 - Introduction
Introduction
155 - QT prolongation
QT prolongation Schizophrenia and related psychoses CHAPTER 1 ECG changes – QT prolongation Intro...
156 - Other ECG changes
Other ECG changes
157 - Quantifying risk
Quantifying risk 162 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 ■ ■There is som...
152 - References
References 158 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 References Rogers JP...